| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/09/2002 | US6369088 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals |
| 04/09/2002 | US6369087 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| 04/09/2002 | US6369086 Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors |
| 04/09/2002 | US6369085 Form of S-omeprazole |
| 04/09/2002 | US6369084 Prostaglandin mediated diseases |
| 04/09/2002 | US6369082 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 04/09/2002 | US6369079 Methods for treating irritable bowel syndrome using optically pure (+) norcisapride |
| 04/09/2002 | US6369078 Solenopsin derivatives and analogues as fire ant suppressants |
| 04/09/2002 | US6369077 Protease inhibitors |
| 04/09/2002 | US6369076 Analgesics |
| 04/09/2002 | US6369075 7[4′-trifluoromethyl-biphenyl-2-carbonyl)amino]-quinoline-3-carboxylic acid amides, and method of inhibiting the secretion of apolipoprotein B |
| 04/09/2002 | US6369073 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
| 04/09/2002 | US6369072 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia |
| 04/09/2002 | US6369071 Treatment of angina pectoris |
| 04/09/2002 | US6369070 Methods for inhibiting mrp1 |
| 04/09/2002 | US6369069 Cardiovascular disorders |
| 04/09/2002 | US6369066 Substituted 1,3-oxathiolanes with antiviral properties |
| 04/09/2002 | US6369065 CD40 signal blocking agent |
| 04/09/2002 | US6369064 Triazolo(4,5-d)pyrimidine compounds |
| 04/09/2002 | US6369062 Sustained release ranolazine formulations |
| 04/09/2002 | US6369061 4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-(3-pyridylmethylamino) -3(2h)-pyridazinone |
| 04/09/2002 | US6369060 Central nervous system disorders such as anxiety; 5-methyl-6-trifluoromethyl-1-(6-(2-methylpyridin-3-yloxy)-pyridin-3-yl carbamoyl)indoline and 5-methyl-1-(6-(2-methylpyridin-3-yloxy) -pyridazin-3-ylcarbamoyl)-6-trifluoromethylindoline |
| 04/09/2002 | US6369059 Tetracyclic derivatives, process of preparation and use |
| 04/09/2002 | US6369058 Intranasally administering |
| 04/09/2002 | US6369056 Agonists and antagonists of the progesterone receptor; contraceptives; 6-(3-chlorophenyl)-4,4-dimethyl-1,4-dihydro -3-oxa-1,8-diaza-naphthalene-2-one and 6-chloro-4,4-dimethyl-1,4-dihydro-3-oxa-1,5-diaza-naphthalen-2-one |
| 04/09/2002 | US6369053 2-Aminoquinolinecarboxamides: neurokinin receptor ligands |
| 04/09/2002 | US6369052 Reverse neuronal dysfunction; alzheimer's; parkinson's disease; amyotrophic lateral sclerosis; strokes; spinal-cord and peripheral nerve injuries; transdermal patch. |
| 04/09/2002 | US6369051 Synergistic mixtures |
| 04/09/2002 | US6369050 Administering amoxicillin and cefdinir to a subject suffering from mixed respiratory infection caused by a plurality of genera of bacteria selected from the group consisting of sreptococcus, moraxella, haemophilus and klebsiella |
| 04/09/2002 | US6369049 Treatment of mastitis |
| 04/09/2002 | US6369048 Methods and compositions for inactivating viruses |
| 04/09/2002 | US6369047 Androgenic steroid compounds and a method of making and using the same |
| 04/09/2002 | US6369046 Administration of a glucocorticoid receptor antagonist, mifepristone |
| 04/09/2002 | US6369045 Phospholipase A2 inhibitors thereof and use of same in diagnosis and therapy |
| 04/09/2002 | US6369043 Metal salt (excluding sodium salt) of lambda-carrageenan, hypertension |
| 04/09/2002 | US6369042 Radical-scavenging functions which counteract pathophysiological disorders especially connected with aging processes; also antidotes against organophosphorous compounds; vitamin b6 antagonists; wound healing promoters |
| 04/09/2002 | US6369040 Incorporating a complementary sequences for herpes, papilloma and other viruses |
| 04/09/2002 | US6369039 Saturated solution; catheter |
| 04/09/2002 | US6369038 Closed antisense and sense oligonucleotides and their applications |
| 04/09/2002 | US6369035 3,6-hemiketals from the class of 9A-azalides |
| 04/09/2002 | US6369032 Method for treating allergies |
| 04/09/2002 | US6369028 For combatting endoparasites |
| 04/09/2002 | US6368855 MHC class II antigen presenting cells containing oligonucleotides which inhibit Ii protein expression |
| 04/09/2002 | US6368846 Ectoparasite saliva proteins and apparatus to collect such proteins |
| 04/09/2002 | US6368831 Treatment of hyperproliferative disorders |
| 04/09/2002 | US6368824 Neuropeptide Y receptor Y5 and nucleic acid sequences |
| 04/09/2002 | US6368818 Methods and compositions for the visualization of cellular organelles using tetrazolium salts |
| 04/09/2002 | US6368816 11-beta-reductase inhibitor such as carbenoxolone to control 11-keto steroid conversion to 11-beta-hydroxysteroid; antidiabetic agents |
| 04/09/2002 | US6368811 Syndecan interacting proteins and the use thereof |
| 04/09/2002 | US6368789 Screening methods to identify inhibitors of telomerase activity |
| 04/09/2002 | US6368640 Method and composition for improving sexual fitness |
| 04/09/2002 | US6368637 Method and composition for topical treatment of viral lesions |
| 04/09/2002 | US6368635 Gastrointestinal mucosa-adherent matrixes pharmaceutical preparations and a coating composition |
| 04/09/2002 | US6368632 Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles |
| 04/09/2002 | US6368627 Compositions |
| 04/09/2002 | US6368626 Semipermeable wall |
| 04/09/2002 | US6368622 Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption |
| 04/09/2002 | US6368621 Preparation in particular for use as a medication and/or food supplement |
| 04/09/2002 | US6368620 Antilipemic agent |
| 04/09/2002 | US6368619 Hydrophobic preparations of hydrophilic species and process for their preparation |
| 04/09/2002 | US6368618 Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs |
| 04/09/2002 | US6368617 Dietary supplement |
| 04/09/2002 | US6368616 Aqueous suspension for nasal administration of loteprednol |
| 04/09/2002 | US6368608 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 04/09/2002 | US6368597 Methods of treating diabetes |
| 04/09/2002 | US6368585 Opthalmic compositions and methods |
| 04/09/2002 | US6368580 Gastrointestinal disorders; oral administering bacillus |
| 04/09/2002 | CA2233698C Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors |
| 04/09/2002 | CA2229000C 1-biphenylimidazole derivatives, their preparation and their therapeutic use |
| 04/09/2002 | CA2228595C Novel water-soluble c-ring analogues of 20 (s)-camptothecin |
| 04/09/2002 | CA2215732C Quinazoline derivatives |
| 04/09/2002 | CA2189731C New 1,4-oxazine tetracyclic compounds, process for preparing the same and pharmceutical compositions containing them |
| 04/09/2002 | CA2184886C Method of strengthening antibacterial action of antibiotics |
| 04/09/2002 | CA2171675C Aromatic heterocyclic compounds; pharmaceutical and cosmetic compositions containing the same and their uses |
| 04/09/2002 | CA2142560C Acronycin analogues; process for preparing the same and pharmaceutical compositions containing them |
| 04/09/2002 | CA2141691C Solid pharmaceutical dosage forms having an extended two-stage release profile and production thereof |
| 04/09/2002 | CA2120229C Methylpiperazinoazepine derivatives, their preparation and their use |
| 04/09/2002 | CA2095338C Individual stereoisomers of 7-¬3-(aminoalkyl)-1-pyrrolidinyl|-quinolonesand naphthyridones as antibacterial agents |
| 04/09/2002 | CA2090321C Therapeutically useful 2-aminotetralin derivatives |
| 04/09/2002 | CA2071224C Quinoline derivatives, their production and use |
| 04/09/2002 | CA2068349C Rapamycin metabolites |
| 04/09/2002 | CA2061239C Polyhydroxycyclopentane derivatives, their preparation and their therapeutic use |
| 04/09/2002 | CA2048842C Substituted pyrimidine derivatives, a process for the preparation thereof and the use thereof as reagents |
| 04/09/2002 | CA2046069C Treatment of inflammatory diseases with 15-keto-prostaglandin compounds |
| 04/09/2002 | CA2033823C Combination of gla or dgla and selenium in psychiatric disorder treatment |
| 04/09/2002 | CA2026384C A solid drug form with a high verapamil content |
| 04/06/2002 | CA2322564A1 Antiviral compounds |
| 04/04/2002 | WO2002027023A2 Genetic determinants for dermal inflammation and immunity |
| 04/04/2002 | WO2002027011A2 Grain fractionation methods and products |
| 04/04/2002 | WO2002027008A1 Promoter sequences |
| 04/04/2002 | WO2002026988A2 Human drug metabolizing enzymes |
| 04/04/2002 | WO2002026950A2 Transferases |
| 04/04/2002 | WO2002026940A1 Compositions and methods for delaying, preventing, rejuvenating or reversing senescence in cells |
| 04/04/2002 | WO2002026845A1 Aqueous polymer dispersion |
| 04/04/2002 | WO2002026762A1 Triterpenes having antibacterial activity |
| 04/04/2002 | WO2002026761A1 Triterpenes having fungicidal activity against yeast |
| 04/04/2002 | WO2002026759A2 17α FLUOROALKYL STEROIDS, METHOD FOR PRODUCING THE SAME AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAID COMPOUNDS |
| 04/04/2002 | WO2002026757A2 Modulation of immunostimulatory activity of immunostimulatory oligonucleotide analogs by positional chemical changes |
| 04/04/2002 | WO2002026753A1 Erythromycin derivatives and medicines containing the same |
| 04/04/2002 | WO2002026752A1 α-SUBSTITUTED β-AMINOETHYL PHOSPHONATES |